Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05286879 · ClinicalTrials.gov registry record · NA

Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations

A NA study of Opioid Use Disorder and Substance Use, sponsored by Yale University.

Active
Registry status
NA
Development phase
600
Enrollment target
3
Study locations

NCT05286879 is a NA study of Opioid Use Disorder and Substance Use that is active but no longer recruiting, run by Yale University. The registered enrollment target is 600 participants, below the 4,654-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (87% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05286879, a NA study of Opioid Use Disorder and Substance Use, is active but no longer recruiting, sponsored by Yale University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
600 participants
Enrollment target
3
Study locations

Study Summary

This is a 5-year Hybrid Type 1 Effectiveness-Implementation Randomized Control Trial (RCT) that compares two models of linking and retaining individuals recently released from justice involvement to the continuum of community-based HIV prevention and treatment, HCV treatment, STI treatment, and opioid use disorder (OUD) prevention and treatment, medication for opioid use disorder (MOUD) service cascades of care.

Conditions Studied

Opioid Use Disorder Substance Use Substance Abuse Infectious Disease Stimulant Use Disorder Risk Reduction Behavior

Interventions

  • BEHAVIORAL Patient Navigator
  • BEHAVIORAL Mobile Health Unit

Study Locations (3)

Texas

  • UT Southwestern - Dallas
  • Texas Christian University - Fort Worth

Connecticut

  • Yale School of Medicine - New Haven

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2022-03-31
Est. Completion 2025-12-31
Phase NA

Sponsor

Yale University

1,492 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05286879

The ClinicalTrials.gov registry entry for NCT05286879 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,654-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (87% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Patient Navigator is the first listed.

NCT05286879 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Texas, Connecticut.

Frequently Asked Questions

What is clinical trial NCT05286879 about?

NCT05286879 is a clinical study titled "Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations". This is a 5-year Hybrid Type 1 Effectiveness-Implementation Randomized Control Trial (RCT) that compares two models of linking and retaining individuals recently released from justice involvement to the continuum of community-based HIV prevention and treatment, HCV treatment, STI treatment, and opio...

What is the current status of trial NCT05286879?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2022-03-31. Estimated completion is 2025-12-31.

What conditions does trial NCT05286879 study?

This clinical trial studies the following conditions: Opioid Use Disorder, Substance Use, Substance Abuse, Infectious Disease, Stimulant Use Disorder.

What interventions are being tested in trial NCT05286879?

The interventions under investigation include: Patient Navigator (BEHAVIORAL), Mobile Health Unit (BEHAVIORAL).

Who is sponsoring clinical trial NCT05286879?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05286879 being conducted?

This trial has 3 study locations across Connecticut, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Opioid Use Disorder

All registered trials for this condition

Substance Use

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.